Technically they are known as FTD's. So yes naked but

New Post Public Reply Private Reply Replies (0) Message Board
Schekin 2015invest #81279
378
Technically they are known as FTD's. So yes naked but legally when sold.

"Failure to deliver is also important when discussing naked short selling. When naked short selling occurs an individual agrees to sell a stock that they neither own nor have borrowed. Subsequently, the failure to deliver creates what are called "phantom shares" in the market which may dilute the price of the underlying stock."

Read more: Failure To Deliver http://www.investopedia.com/terms/f/failureto...z4ojU4d3IB
or...
https://en.wikipedia.org/wiki/Failure_to_deliver or
In finance, a failure to deliver (plural fails-to-deliver) is the inability of a party to deliver a tradable asset, or meet a contractual obligation. A typical example is the failure to deliver shares as part of a short transaction. The Securities and Exchange Commission publishes "fails-to-deliver" data regarding transactions in the United States.[1]

As a remedy for this in the United States, Regulation SHO was designed.[2] Stocks bought and sold in transaction must be settled within 3 days. The buyer must deliver the cash and the seller the stock. If either party fails, a failure-to-deliver takes place.[3]

Sometimes deliberate fails-to-deliver are used to profit from falling stocks (see Bear market), so that the stock can later be purchased at a lower price, then delivered, e.g. in the week of March 10, 2008, just before the failure of Bear Stearns, the fails-to-deliver increased by 10,800 percent.[3]

According to CNN in the US markets, fails-to-deliver had reached $200 billion a day in September 2011, but no similar data has been available for Europe.[4]

A study of fails to deliver, published in the Journal of Financial Economics in 2014, found no evidence that FTDs "caused price distortions or the failure of financial firms during the 2008 financial crisis." Researchers studied 1,492 New York Stock Exchange stocks over a 42-month period from 2005 to 2008, and found that "greater FTDs lead to higher liquidity and pricing efficiency, and their impact is similar to our estimate of delivered short sales." [5][6][7]

A 2016 Journal of Empirical Finance study broader in scope than that by Fotak, et al, found that indeed pricing abnormalities of Russell 3000 stocks with high delivery failures can be attributed to the market distorting effect of the sustained fails.

Nanotech Entertainment Inc. (NTEK) Stock Research Links

NTEK Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 59

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 60

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 72

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 58

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 67

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 78

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 80

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading

Top 5 Most Recently Viewed Articles

EYLEA HD® Injection Receives FDA Approval for RVO Treatment

Updated Category News Views 146

EYLEA HD® Injection: A Milestone in Treating Macular Edema First and only FDA-approved treatment for retinal vein occlusion (RVO) indicated for up to every 8-week dosing after an initial monthly regimen. Flexible Dosing Options for Enhanced Patient Care The recent FDA approval for EYLEA HD® (aflibercept) Injection 8 mg is a major advancement. This treatment is...

Continue Reading
Trifork Group's Recent Share Buyback Program Overview

Updated Category News Views 188

Overview of Trifork Group's Share Buyback Program The Trifork Group has recently initiated a significant share buyback program to enhance shareholder value and optimize its capital structure. This strategic decision underscores the company's commitment to returning value to its investors while maintaining a strong financial position. Details of the Share Buyback...

Continue Reading
Raymond James Celebrates Unmatched Milestone of 150 Quarters

Updated Category News Views 150

Remarkable Achievement in Consistent Profitability Raymond James has proudly reached a significant milestone of 150 consecutive quarters of profitability, showcasing nearly four decades of unwavering strength. This accomplishment highlights the firm’s resilience and dedication to its values. Guided by seasoned leaders including Chair Emeritus Tom James, Chair Paul...

Continue Reading
Innovative Cozy Sleeper Berth Light Designed for Truckers

Updated Category News Views 178

Introducing the Cozy Sleeper Berth Light The Cozy Sleeper Berth Light, developed by an innovative inventor, aims to transform the way truck drivers experience rest periods. This convenient lighting solution addresses the common issue of harsh lighting or total darkness that many drivers face while resting in their sleeper berths. The Invention's Unique Features The Cozy...

Continue Reading
ON Semiconductor Drives Innovation Amid Chip Market Changes

Updated Category News Views 141

ON Semiconductor's Recent Performance ON Semiconductor Corp (NASDAQ: ON) has recently experienced a boost following its latest earnings report. The company shared its fiscal third-quarter results, leading to an increase in stock value, reflecting investor confidence amidst ongoing fluctuations in the semiconductor sector. Quarterly Financial Highlights The latest figures...

Continue Reading